Eye drug could be used for hair loss
A SIDE EFFECT of a common eye drug could lead to its use as a baldness treatment, say researchers.
Lumigan is administered as eye drops to patients with glaucoma, a condition caused by excess fluid in the eye that leads to vision loss.
But it has one marked side effect – it can stimulate the growth of eyelashes.
The new research suggests the active ingredient in Lumigan, bimatoprost, has the same effect on the scalp.
Business Cards From Only £10.95 Delivered www.myprint-247.co.ukView details
Our heavyweight cards have FREE UV silk coating, FREE next day delivery & VAT included. Choose from 1000's of pre-designed templates or upload your own artwork. Orders dispatched within 24hrs.
Terms: Visit our site for more products: Business Cards, Compliment Slips, Letterheads, Leaflets, Postcards, Posters & much more. All items are free next day delivery. www.myprint-247.co.uk
Contact: 01858 468192
Valid until: Wednesday, May 22 2013
Tests identified a previously unknown molecular signalling pathway linked to hair growth from follicles.
Trials are now under way to see whether bimatoprost can reverse hair loss in both men and women. If successful, it may not be long before the drug is re-marketed as a baldness treatment.
Lead scientist Professor Valerie Randall, from the University of Bradford, said: "Bimatoprost is known to stimulate eyelash growth and is already used clinically for this purpose. We wanted to see whether it would have the same effect on scalp hair, as the two types of follicle are very different.
"Our findings show bimatoprost does stimulate growth in scalp hair follicles and therefore could offer a new approach for treating hair loss disorders."